BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 16279769)

  • 1. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.
    Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cirilli R; La Torre F; Cardia MC; Distinto S
    J Med Chem; 2005 Nov; 48(23):7113-22. PubMed ID: 16279769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
    J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.
    Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Rossi F; Turini P; Ortuso F; Alcaro S; Cardia MC
    Eur J Med Chem; 2008 Oct; 43(10):2262-7. PubMed ID: 18281126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives.
    Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cardia MC; Distinto S
    J Med Chem; 2007 Feb; 50(4):707-12. PubMed ID: 17253676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives.
    Palaska E; Aydin F; Uçar G; Erol D
    Arch Pharm (Weinheim); 2008 Apr; 341(4):209-15. PubMed ID: 18266289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors.
    Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Befani O; Turini P; Ortuso F; Alcaro S
    J Med Chem; 2007 Feb; 50(3):425-8. PubMed ID: 17266193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.
    Chimenti F; Carradori S; Secci D; Bolasco A; Bizzarri B; Chimenti P; Granese A; Yáñez M; Orallo F
    Eur J Med Chem; 2010 Feb; 45(2):800-4. PubMed ID: 19926363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics.
    Gökhan-Kelekçi N; Yabanoğlu S; Küpeli E; Salgin U; Ozgen O; Uçar G; Yeşilada E; Kendi E; Yeşilada A; Bilgin AA
    Bioorg Med Chem; 2007 Sep; 15(17):5775-86. PubMed ID: 17611112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
    Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
    Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantiomers of C(5)-chiral 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives: Analytical and semipreparative HPLC separation, chiroptical properties, absolute configuration, and inhibitory activity against monoamine oxidase.
    Cirilli R; Ferretti R; Gallinella B; Turchetto L; Bolasco A; Secci D; Chimenti P; Pierini M; Fares V; Befani O; La Torre F
    Chirality; 2004 Nov; 16(9):625-36. PubMed ID: 15382204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Cirilli R; La Torre F; Alcaro S; Ortuso F; Langer T
    Curr Med Chem; 2006; 13(12):1411-28. PubMed ID: 16719786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
    Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
    Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of human monoamine oxidase inhibitory activities of some 3,5-diaryl-N-substituted-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives.
    Sentürk K; Tan OU; Ciftçi SY; Uçar G; Palaska E
    Arch Pharm (Weinheim); 2012 Sep; 345(9):695-702. PubMed ID: 22674756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of N,N'-bis[2-oxo-2H-benzopyran]-3-carboxamides.
    Chimenti F; Secci D; Bolasco A; Chimenti P; Granese A; Carradori S; Befani O; Turini P; Alcaro S; Ortuso F
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4135-40. PubMed ID: 16759860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones.
    Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Carradori S; Alcaro S; Ortuso F; Yáñez M; Orallo F; Cirilli R; Ferretti R; La Torre F
    J Med Chem; 2008 Aug; 51(16):4874-80. PubMed ID: 18666768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
    Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
    J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors.
    Chimenti F; Secci D; Bolasco A; Chimenti P; Granese A; Carradori S; Maccioni E; Cardia MC; Yáñez M; Orallo F; Alcaro S; Ortuso F; Cirilli R; Ferretti R; Distinto S; Kirchmair J; Langer T
    Bioorg Med Chem; 2010 Jul; 18(14):5063-70. PubMed ID: 20579890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    Gökhan-Kelekçi N; Koyunoğlu S; Yabanoğlu S; Yelekçi K; Ozgen O; Uçar G; Erol K; Kendi E; Yeşilada A
    Bioorg Med Chem; 2009 Jan; 17(2):675-89. PubMed ID: 19091581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.